Related references
Note: Only part of the references are listed.Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
Joseph A. Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?
Vasiliki Siozopoulou et al.
CANCERS (2021)
The Sarcoma Immune Landscape: Emerging Challenges, Prognostic Significance and Prospective Impact for Immunotherapy Approaches
Anna Koumarianou et al.
CANCERS (2021)
Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
Rui Shen et al.
BMC CANCER (2021)
Identification of Tumor Microenvironment-Related Prognostic Genes in Sarcoma
Dongjun Dai et al.
FRONTIERS IN GENETICS (2021)
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
Eve Merry et al.
NPJ PRECISION ONCOLOGY (2021)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets
Jordan L. Kohlmeyer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
Jessica Roelands et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer
Bernhard Mlecnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Comprehensive profiling of immune-related genes in soft tissue sarcoma patients
Chuan Hu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma
Jeffrey C. Thompson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting
Berengere Dadone-Montaudie et al.
CANCERS (2020)
Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy
Amy J. Wisdom et al.
NATURE COMMUNICATIONS (2020)
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies
Maud Toulmonde et al.
EBIOMEDICINE (2020)
Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma
A. Dufresne et al.
ONCOIMMUNOLOGY (2020)
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
Naotaka Hayasaka et al.
SCIENTIFIC REPORTS (2019)
Pathological grade-independent prediction of chemosensitivity by CINSARC should rehabilitate adjuvant chemotherapy in soft tissue sarcomas of any grade
F. Bertucci et al.
ANNALS OF ONCOLOGY (2019)
Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
Lingjian Yang et al.
ONCOTARGET (2018)
Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas
S. Le Guellec et al.
ANNALS OF ONCOLOGY (2018)
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. G. Casali et al.
ANNALS OF ONCOLOGY (2018)
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
Francois Bertucci et al.
BRITISH JOURNAL OF CANCER (2018)
The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma
F. Bertucci et al.
ANNALS OF ONCOLOGY (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
PDL1 expression is a poor- prognosis factor in soft-tissue sarcomas
Francois Bertucci et al.
ONCOIMMUNOLOGY (2017)
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
Wouter Hendrickx et al.
ONCOIMMUNOLOGY (2017)
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li et al.
JAMA ONCOLOGY (2017)
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Alexander J. Lazar et al.
CELL (2017)
Therapeutic applications of histone deacetylase inhibitors in sarcoma
Fan Tang et al.
CANCER TREATMENT REVIEWS (2017)
A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma
Ninna Aggerholm-Pedersen et al.
BRITISH JOURNAL OF CANCER (2016)
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Olivier Mir et al.
LANCET ONCOLOGY (2016)
Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways
A. Nabeshima et al.
BRITISH JOURNAL OF CANCER (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Clinically Relevant Molecular Subtypes in Leiomyosarcoma
Xiangqian Guo et al.
CLINICAL CANCER RESEARCH (2015)
Gene Expression Signatures as Biomarkers of Tumour Hypoxia
B. H. L. Harris et al.
CLINICAL ONCOLOGY (2015)
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
Yong Feng et al.
ONCOTARGET (2015)
MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent In Vitro and In Vivo Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma
Emily K. Slotkin et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali et al.
ANNALS OF ONCOLOGY (2014)
Endo Predict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer
Francois Bertucci et al.
CANCER LETTERS (2014)
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Jerome Galon et al.
IMMUNITY (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas
Marcus Renner et al.
GENOME BIOLOGY (2013)
Gene expression identifies heterogeneity of metastatic propensity in high-grade soft tissue sarcomas
Keith M. Skubitz et al.
CANCER (2012)
The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study
Kristen N. Ganjoo et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling
Domenico Coppola et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Integrative Genomic Characterization and a Genomic Staging System for Gastrointestinal Stromal Tumors
Antti Ylipaa et al.
CANCER (2011)
Expression Profiling of Liposarcoma Yields a Multigene Predictor of Patient Outcome and Identifies Genes That Contribute to Liposarcomagenesis
Ryan M. Gobble et al.
CANCER RESEARCH (2011)
New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics
Laure Gibault et al.
JOURNAL OF PATHOLOGY (2011)
Kinome expression profiling and prognosis of basal breast cancers
Renaud Sabatier et al.
MOLECULAR CANCER (2011)
Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
Sveinung W. Sorbye et al.
PLOS ONE (2011)
IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting
Mihai Hajdu et al.
JOURNAL OF PATHOLOGY (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
Frederic Chibon et al.
NATURE MEDICINE (2010)
Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling
A. H. Beck et al.
ONCOGENE (2010)
A pathway-based classification of human breast cancer
Michael L. Gatza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic significance of macrophage infiltration in leiomyosarcomas
Cheng-Han Lee et al.
CLINICAL CANCER RESEARCH (2008)
Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma
Robert Nakayama et al.
MODERN PATHOLOGY (2007)
Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas:: hypoxia-induced transcription profile signifies metastatic potential
Princy Francis et al.
BMC GENOMICS (2007)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E. Teschendorff et al.
GENOME BIOLOGY (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene expression profiling of human sarcomas: Insights into sarcoma biology
K Baird et al.
CANCER RESEARCH (2005)
Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A
KY Detwiller et al.
CANCER RESEARCH (2005)
Determination of stromal signatures in breast carcinoma
RB West et al.
PLOS BIOLOGY (2005)
A molecular map of mesenchymal tumors
SR Henderson et al.
GENOME BIOLOGY (2005)
A gene expression signature associated with metastatic outcome in human leiomyosarcomas
YF Lee et al.
CANCER RESEARCH (2004)
Molecular characterisation of soft tissue tumours: a gene expression study
TO Nielsen et al.
LANCET (2002)
Gene expression profiling of cancer by use of DNA arrays: how far from the clinic?
F Bertucci et al.
LANCET ONCOLOGY (2001)
Share Paper
